Pediatrix Medical

MD

Market cap $1.89B

MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.

Investors target stocks that have been on a bullish run. Stocks like KSS, HRTG, MD and NEM are seeing price strength, and the momentum is likely to continue.

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MD, LZB and CIB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Nov. 24, 2025.

AS, ISRG, MD, SHIP and CIB have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 24, 2025.

JBSS, CIB and MD made it to the Zacks Rank #1 (Strong Buy) value stocks list on Nov. 24, 2025.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

MD's Q3 profit tops on lower expenses and improved patient acuity, driving earnings past estimates despite softer revenues.

Pediatrix Medical Group, Inc. ( MD ) Q3 2025 Earnings Call November 3, 2025 9:00 AM EST Company Participants Mary Ann Moore - Chief Administrative Officer, Executive VP, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Kieran Ryan - Deutsche Bank AG, Research Division Jack Slevin - Jefferies LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Hello. My name is Dustin, and I will be your conference operator today.